Based in Durham, North Carolina, Xilis, Inc. is a biotechnology company developing a precision oncology platform that guides treatment decisions for oncologists to improve cancer care outcomes for patients and supports drug discovery and development for pharmaceutical companies. Xilis’ proprietary MicroOrganoSpheres (MOS) are miniature patient tumors that capture the full microenvironment and heterogeneity and provide an automated and scalable solution. Using MOS, high-throughput automation, and AI-driven algorithms, Xilis is developing a Xilis Response Score™ for the clinic, enabling oncologists to make informed and timely treatment decisions. Additionally, the MOS technology is speeding up the development and clinical trials of cancer drugs by enabling analysis of authentic tumor microenvironments, high-throughput preclinical modeling, and clinical patient selection capabilities.

We are supported in this mission by top Silicon Valley, New York, and international venture firms that are leaders in the healthcare space and have invested in top precision medicine companies including Foundation Medicine and Guardant Health.

Based in Durham, North Carolina, Xilis, Inc. is a biotechnology company developing a precision oncology platform that guides treatment decisions for oncologists to improve cancer care outcomes for patients and supports drug discovery and development for pharmaceutical companies. Xilis’ proprietary MicroOrganoSpheres (MOS) are miniature patient tumors that capture the full microenvironment and heterogeneity and provide an automated and scalable solution. Using MOS and AI-driven algorithms, Xilis is developing a Xilis Response Score™ for the clinic, enabling oncologists to make informed and timely treatment decisions. Additionally, the MOS technology is speeding up the development and clinical trials of cancer drugs by enabling analysis of authentic tumor microenvironments, high-throughput preclinical modeling, and clinical patient selection capabilities.

We are supported in this mission by top Silicon Valley, New York and international venture firms that are leaders in the healthcare space and have invested in top precision medicine companies including Foundation Medicine and Guardant Health.

The candidate will be responsible for the coordination of sample accessioning and communications with vendors of the purpose of sample management. Other responsibilities will include assisting with the management of laboratory inventory and other recurring laboratory duties. The successful candidate will bring exceptional skills and abilities to the laboratory. He or she will also have strong attention to detail and the integrity to precisely report any deviation or issue observed in the laboratory. Finally, the candidate’s communication skills will be stellar. The candidate will report to Xilis’ Senior Manager of Laboratory Operations.

By joining the team at an early stage, the candidate will have an outsized impact on fundamentally advancing precision cancer care therapy.

Xilis was created when its three founders — an engineer, a physician, and a biologist — decided to come together and commercialize their technology to transform cancer care. We are committed to building a team that represents a variety of backgrounds, perspectives, and skills. We do not discriminate on the basis of race, color, ancestry, religion, sex, national origin, sexual orientation, age, citizenship, marital status, disability, gender identity, or Veteran status. Furthermore, even if your work experience isn't perfectly aligned with what we've described above, if you're excited about what we're building then we want to talk to you!

Xilis offers comprehensive health, vision, dental & retirement plans, and unlimited PTO. We are a remote-friendly team: our headquarters are in Durham, North Carolina, but we have team members across the US (and beyond!).